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Previous studies have shown that agonists of GPR17 stimulate, while antagonists inhibit
feeding. However, whole body knockout of GPR17 in mice of the C57Bl/6 strain did not
affect energy balance, whereas selective knockout in oligodendrocytes or pro-
opiomelanocortin neurons provided protection from high fat diet-induced obesity and
impaired glucose homeostasis. We reasoned that whole body knockout of GPR17 in mice
of the 129 strain might elicit more marked effects because the 129 strain is more
susceptible than the C57Bl/6 strain to increased sympathetic activity and less
susceptible to high fat diet-induced obesity. Consistent with this hypothesis, compared
to wild-type mice, and when fed on either a chow or a high fat diet, GPR17 -/- mice of the
129 strain displayed increased expression of uncoupling protein-1 in white adipose tissue,
lower body weight and fat content, reduced plasma leptin, non-esterified fatty acids and
triglycerides, and resistance to high fat diet-induced glucose intolerance. Not only energy
expenditure, but also energy intake was raised. Administration of leptin did not suppress
the increased food intake in GPR17 -/- mice of the 129 strain, whereas it did suppress
food intake in GPR17 +/+ mice. The only difference between GPR17 +/- and GPR17 +/+
mice of the C57Bl/6 strain was that the body weight of the GPR17 -/- mice was lower than
that of the GPR17 +/+ mice when the mice were fed on a standard chow diet. We propose
that the absence of GPR17 raises sympathetic activity in mice of the 129 strain in
response to a low plasma fuel supply, and that the consequent loss of body fat is partly
mitigated by increased energy intake.
Keywords: GPR 17 knockout mouse, genetic background, high fat diet, body composition, leptin resistance, energy
expenditure, energy intaken.org September 2021 | Volume 12 | Article 6981151
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The worldwide prevalence of obesity has more than doubled
since 1980. This rapid rise forecasts an increased burden from
several diseases, most notably type 2 diabetes mellitus (1). The
thrifty genotype hypothesis postulates that both obesity and type
2 diabetes mellitus are caused by a positive selection of genotypes
for efficient metabolism and fat storage (2). Thus, identifying
biochemical pathways to target these genes, that are amenable to
pharmacological manipulation, holds promise for developing
novel therapies for the treatment of metabolic disease.
Intracerebroventricularly-administered agonists of G protein-
coupled receptor 17 (GPR17) stimulate and antagonists inhibit
feeding, with the agonists promoting insulin resistance in
response to high fat diet (3). GPR17 is a transcriptional target
of FoxO1 (3, 4). FoxO1 expression is reduced by the anorexigenic
hormones insulin and leptin. The effects of these hormones on
feeding are inhibited by FoxO1 expression, increasing food
intake (5), whereas mice that lacked FoxO1 in Agouti-related
peptide neurones displayed reduced food intake, and were lean,
with improved glucose homeostasis, and increased sensitivity to
insulin and leptin (3). Leptin is released fromadipocytes and signals
the size of lipid stores and manifests mechanisms that affect
metabolism, the metabolic syndrome and its cardiovascular
complications (6, 7). Low levels stimulate feeding and reduce
energy expenditure (8), but the ability of high levels to inhibit
feeding is limited by the phenomenon of leptin resistance (9).
Mice that lack GPR17 might be predicted to have similar
(beneficial) metabolic phenotypes to those that lack FoxO1.
However, whole-body GPR17 null mice had similar food intake,
bodyweight,metabolic rate andglucose homeostasis, in response to
a high fat diet compared to wild-type mice (10). By contrast,
selective knockout of GPR17 primarily in oligodendrocytes
provided protection from high fat diet-induced obesity (11) and
knocking out GPR17 in pro-opiomelanocortin neurons attenuated
the metabolic effects of high fat diet on body weight and adiposity,
most noticeably in female mice (12). Activation of pro-
opiomelanocortin neurons increases sympathetic activity (13), so
it is possible that increased sympathetic activity is the mechanism
that linksGPR17knockout, inpro-opiomelanocortinneurons,with
increased oxygen consumption. Sympathetic activation is a major
influence on browning of adipose tissue (14, 15).
All the above cited studies on GPR17 null mice were
conducted on mice, of the C57Bl/6 background strain. Wild-
type C57Bl/6 mice have a lower capacity for browning of white
adipose tissue (WAT) compared to mice of the 129 strain (16–
20). Browning of WAT has been shown to protect against the
metabolic effects of high fat diet (21–24), which may be why
C57Bl/6 mice are more susceptible than 129 mice to the effects of
high fat feeding (17–19, 25). We have therefore compared the
effect of knocking out GPR17 on energy balance and glucose
homeostasis in mice on C57Bl/6J and 129 backgrounds. We
report beneficial changes in mice of the 129 but not the C57Bl/
6J strain.
Interestingly, the knockout of GPR17 in mice on the 129
background not only makes them leaner with a higher energy
expenditure than wildtype mice, but also their energy intake isFrontiers in Endocrinology | www.frontiersin.org 2raised. This condition is found in various other transgenic
rodents, drug- or hormone-treated rodents and humans, and
in response to exercise, but the mechanisms that stimulate
energy intake have not been studied in detail. We show that
increased energy intake in GPR17 null 129 mice cannot be due to
low leptin levels because it is not suppressed by administration of
exogenous leptin.MATERIALS AND METHODS
Reagents were obtained from Sigma-Aldrich, Poole, UK, unless
otherwise stated.
Animals
Animal procedures were conducted in accordance with
University of Buckingham project licence, under the UK
Animals (Scientific Procedures Act (1986)) and as approved by
the University’s Ethical Review Board. Three male and two female
GPR17 -/- mice on a mixed 129 and C57Bl/6J background were
donated by Professor Lu, Cincinnati Children’s Hospital,
Cincinnati, USA. Genotypes were backcrossed for ten generations
onto either a C57Bl/6NCrl or 129S2/SvPasCrl (Charles River,
Germany). Twelve male and twelve female GPR17 +/+ and
GPR17 -/- mice on 129 and C57Bl/6J background were fed a
standard rodent diet (chow, n = 12; 10% fat, 70% carbohydrate
and 20% protein by energy, Beekay Feed, B&KUniversal Ltd., UK)
or high fat diet (HFD, n = 12; 60% fat by energy value; Research
Diets, NewBrunswick,New Jersey; catD12492) fromage 5-6weeks
for 18weeks.Micewerehoused inpairs at 19–22°Cwith lights onat
08.00h, lights off at 20.00h, and were fed ad libitum.
Food Consumption and Body Parameters
Mice were weighed at 23 to 24 weeks of age, when some had been
on the HFD for 18 weeks. Body fat and lean content were
measured using a Minispec LF90II Nuclear Magnetic
Resonance (Bruker Corporation, Germany). Food consumption
was then recorded for three consecutive days. From the evening
of the day of the final measurement of food consumption, they
were fasted overnight for 16 hours then re-fed. Food consumption
was measured one hour after re-feeding. After two days, all mice
were placed in clean cages without food 4 hours prior to lights out.
Immediately prior to lights out, they were given an i.p. dose of
either 5 ml.kg-1 saline or 20 mg.kg+1 leptin. All food consumption
values are expressed as digestible energy content in kJ units.
Energy expenditure was measured by open circuit indirect
calorimetry, with mice in their home cages (26, 27). It was
calculated from the flow of air exiting the respiratory chamber
and the oxygen content of that air without removing CO2. This
gives a more accurate estimate of energy expenditure than oxygen
consumption provides (27–31).
Oral Glucose Tolerance Test
After fasting for five hours, mice were dosed with glucose (3 g.kg-1,
body weight PO by gavage). Blood samples were collected from the
tail at -30, 0, + 30, +60 and +120 minutes, relative to glucose dosing.
Blood glucose was measured using a glucose oxidase reagent kitSeptember 2021 | Volume 12 | Article 698115
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(t -30 min) was measured by ELISA (Ultra-Sensitive Mouse Insulin
ELISA kit, Catalog #: 90080; Crystal Chem, Downers Grove,
IL, USA).
Plasma Measurements
After fasting for five hours, blood samples were collected from
the tail. Plasma leptin was measured by ELISA (Catalog # 90030;
Chrystal Chem). Plasma NEFA (Catalog # FA115; Randox,
Crumlin, UK) and triglycerides (Catalog # TR210; Randox,
Crumlin, UK) were measured by colorimetric assay.
Termination
At 24 weeks of age all mice were culled by concussion followed by
cervical dislocation. Interscapular, perigenital and inguinal fat
pads were dissected and weighed, the perigenital and inguinal
weights presented being the average of the two pads for each.
Inguinal fat pads were stored at -80°C for mRNA analysis.
Inguinal Fat UCP-1 mRNA Analysis Using
TaqMan RT-PCR
RNA analysis of UCP-1 in the inguinal fat was carried out using
Micro Fluidic Cards (Applied Biosystems, Foster City, CA, USA)
in accordance with the manufacturer’s protocol. The reactions
were performed in duplicate for each sample using an Applied
Biosystems 7900HT fast real-time PCR system. A standard curve
was constructed for each gene using a serial dilution of cDNA
from samples. The mean CT values of the GPR17+/+ were then
used to calculate the relative expression for each sample in the
respective diet/sex cohort and data were normalized to Ppia
(cyclophilin). ATPAF1 was used as an internal control. Real time
PCR (StepOne™, Applied Biosystems) was carried out using
Assay on Demand pre-designed primer and probe sets (n = 12).
Data were analyzed using the comparative DCt method.
Statistical Analysis
A priori power analysis was conducted using G*Power3 (32).
Data are presented as mean ± SEM. The Student’s t-test was
utilized for statistical comparisons, except for leptin-induced
energy intakes, which were analyzed by 2-way ANOVA
(factors: leptin and genotype). All data sets passed the
Anderson-Darling test for normality of distribution (alpha of
0.05). The ROUT method was used to analyse data sets for
outliers. No outliers were identified.RESULTS
GPR17 -/- 129 Mice Had Less Body Fat
Than GPR17 +/+ Mice but There Was No
Such Difference in C57Bl/6J Mice
Both male (p < 0.01) and female (p < 0.01) GPR17 -/- 129 mice
had a lower whole-body weight’than GPR17 +/+ mice
(Figures 1A, B). The difference remained when the mice were
fed HFD for 18 weeks (p < 0.0001 for both males and females).
This was due to fat mass being lower in the GPR17 -/- miceFrontiers in Endocrinology | www.frontiersin.org 3(males: p < 0.0001 on both chow and HFD; Figure 1C; females:
p < 0.05 on chow, p < 0.0001 on HFD; Figure 1D), there being no
difference in lean mass between GPR17 +/+ and +/- mice of
either sex (Figures 1E, F).
Female but not male GPR17 -/- C57Bl/6J mice fed on chow
had a lower whole-body weight than GPR17 +/+ (p < 0.01), but
there were no differences in fat or lean mass between GPR17 +/+
and -/- genotypes in C57Bl/6J mice of either sex (Figure 1).
GPR17 -/- 129, but Not C57Bl/6J, Mice on
a High Fat Diet Had Smaller Adipose
Tissue Depots
On a standard chow diet, male mice had smaller perigenital (p <
0.001, Figure 2C) and inguinal (p < 0.001, Figure 2E), but not
interscapular fat pads (Figure 2A). Female GPR17 -/- 129 mice
on standard chow also had smaller inguinal (p < 0.0001,
Figure 2F) but not interscapular or perigenital fat pads
(Figures 2B, D). Both male and female GPR17 -/- 129 mice
fed the HFD had significantly smaller interscapular, perigenital
and inguinal fat pad depots than GPR17 +/+ mice
(Figures 2A–F).
There was no statistically significant difference in fat pad
weight between the genotypes on a C57Bl/6 background of either
sex (Figure 2).
GPR17 -/- 129, but Not GPR17 -/- C57Bl/
6J, Mice Exhibited Increased Energy
Intake and Energy Expenditure
Despite being lighter and leaner, both male (p < 0.01, Figure 3A)
and female (p < 0.01, Figure 3B) GPR17 -/- 129 mice had
increased energy intake at 24 weeks of age. This was also the case
when the mice were fed a HFD (p < 0.05). Food consumption was
also higher in GPR17 +/- than GPR17 +/+ 129 mice after a 16
hour overnight fast, (p < 0.01 for males, Figure 3C); p < 0.01 for
females, Figure 3D). The increase in feeding following a fast also
occurred with the HFD (p < 0.01 for both males and females).
There were no effects of genotype on energy intake in C57Bl/6J
mice (Figure 3).
To allow comparison with the energy intake data and because
energy expenditure relative to body weight is affected by body
composition (25), energy expenditure is expressed per animal.
Both chow-fed male (p < 0.01, Figure 4A) and female (p < 0.01,
Figure 4B) GPR17 -/- mice had increased twenty-four-hour
energy expenditure at 24 weeks of age. Energy expenditure was
also increased in GPR17 -/- mice fed on a HFD (p < 0.05 for
males and p < 0.001 for females). No differences were found
between GPR17 +/+ and -/- genotypes in C57Bl/6J
mice (Figure 4).
GPR17 -/- 129 Mice, but Not C57Bl/6J
Mice, Were Protected Against HFD-
Induced Glucose Intolerance and
Insulin Resistance
18 weeks of HFD induced glucose intolerance in GPR17 +/+
mice. This effect was significantly attenuated in the GPR17 -/-
129 mice (p < 0.001 in males, Figures 5A, B, E; p < 0.01 inSeptember 2021 | Volume 12 | Article 698115
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plasma insulin induced by HFD was significantly reduced in in
the GPR17 -/- 129 mice (p < 0.01 in males, Figure 5G; p < 0.001
in females, Figure 5H). There was no difference between chow-
fed C57Bl/6J and 129 mice in fasting blood glucose concentration
in both males and females. No differences in either glucose
tolerance or plasma insulin were found between GPR17 +/+
and -/- genotypes in C57Bl/6J mice (Figure 5).
GPR17 -/- Mice Had Elevated UCP-1 Gene
Expression in Inguinal Fat
Both chow-fed male (p < 0.05, Figure 6A) and female (p < 0.05,
Figure 6B) GPR17+/- mice on the 129 background hadFrontiers in Endocrinology | www.frontiersin.org 4increased inguinal fat UCP-1 gene expression. Inguinal fat
UCP-1 was also increased in GPR17 -/- 129 mice fed a HFD
(p < 0.0001 for males and p < 0.01 for females). No differences
were found in UCP-1 gene expression between GPR17 +/+ and -/-
genotypes in C57Bl/6J mice (Figure 6).
Plasma Lipids and Leptin Levels Were
Lower in GPR17 -/- 129 mice, but Not
C57Bl/6 Mice
When fed on the chow diet, both male (p < 0.0001) and female
(p < 0.0001) GPR17 -/- 129 mice had lower plasma leptin
concentrations compared to GPR17 +/+ mice (Figures 7A, B).




FIGURE 1 | Body weight [(A) males, (B) females], fat mass (C) males, (D) females] and lean mass [(E) males, (F) females] in GPR17 +/+ (white bars) and GPR17 -/-
(black bars) 129 and Bl6 mice fed standard chow or high fat diet for 18 weeks from age 6 weeks. N = 12 per group). ★P<0.05; ★★P<0.01; ★★★★P<0.0001.
Values are expressed as means ± S.E.M.September 2021 | Volume 12 | Article 698115
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females) . Plasma non-esterified fatty acids (NEFA)
concentration was also lower in the GPR17 -/- mice (males:
p < 0.01 on chow and p < 0.05 on HFD, Figure 7C; females: p <
0.05 on both chow and HFD, Figure 7D). Similarly, plasma
triglycerides concentration was lower in GPR17 -/- mice (males:
p < 0.01 on chow and HFD, Figure 7E; females: p < 0.01 on both
chow and HFD, Figure 7F).
No effects of genotype on plasma leptin, NEFA or
triglycerides were found in C57Bl/6J mice (Figure 7).
Leptin Reduced Energy Intake in
GPR17 +/+ but Not -/- 129 Mice
To investigate a possible role of low leptin levels in increased
energy intake in GPR17 -/- 129 mice, food intake was measured
following administration of leptin. Contrary to this hypothesis,
leptin did not reduce food intake in male or female GPR17 -/-
129 mice on either diet, whereas it did reduce food intake inFrontiers in Endocrinology | www.frontiersin.org 5GPR17 +/+ 129 mice (males: p < 0.05 on chow, < 0.0001 on HFD;
females: p < 0.01 on chow, < 0.0001 on HFD; Figures 8A, B).
By contrast, leptin reduced food inake in both GPR17 +/+ and
-/- genotypes in C57Bl/6J mice, there being no difference
between the GPR17 genotypes (Figures 8A, B).DISCUSSION
We have compared the effect of knocking out GPR17 on energy
balance and glucose handling in mice on a C57Bl/6J background,
which are considered susceptible to high fat feeding, and in mice
on a 129 background, which are considered to be resistant (23).
Both male and female mice, and mice fed on a chow diet or on a
high fat diet for 18 weeks from the age of six weeks were
compared. Compared to wild type mice and irrespective of
their sex or diet, GPR17 -/- mice on a 129 background were




FIGURE 2 | Fat pad weights in GPR17 +/+ (white bars) and GPR17 -/- (black bars) 129 and Bl6 mice fed standard chow or high fat diet for 18 weeks from age
6 weeks. Interscapular fat pad [(A) males, (B) females]; perigenital fat pad [(C) males, (D) females]; inguinal fat pad [(E) males, (F) females]. (N = 12 per group).
★P<0.05; ★★P<0.01; ★★★P<0.001; ★★★★P<0.0001. Values are expressed as means ± S.E.M.September 2021 | Volume 12 | Article 698115
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be more marked if the results were expressed relative to body
weight because the GPR17 -/- mice are lighter than the GPR17
+/+ mice). They were also less glucose intolerant than the wild
type mice after they had been fed on the high fat diet. Other than
a reduction in body weight when the female mice were fed on
chow, none of these differences between GPR17 -/- and wild type
mice were found in mice on a C57Bl/6J background. Again,
irrespective of their sex or diet, GPR17 -/- mice on a 129
background, but not mice on the C57Bl/6J background, had
increased inguinal fat UCP-1 gene expression compared to
wildtype mice.
A possible explanation that links all these findings is that
GPR17 -/- mice on a 129 but not on a C57Bl/6J background had
increased sympathetic activity. Thus, sympathetic activation is
the major influence on browning of adipose tissue (14, 15); wild-
type C57Bl/6 mice have a lower capacity for browning of white
adipose tissue than mice of the 129 strain (17–19, 23); and
sympathomimetic agents, such as b3-adrenoceptor agonists,
display all the beneficial effects on energy balance and glucose
homeostasis that we report here (33, 34). We chose to measure
the level of UCP-1 mRNA in white adipose tissue because it is a
well-established marker of sympathetic activity. Consistent with
our hypothesis, this was increased in GPR17 -/- mice on a 129
but not on a C57Bl/6J background. Studies that directly measure
sympathetic activity are needed to confirm our hypothesis. In
addition, studies in primary cultures of preadipocytes from mice
of both strains and genotypes would show whether differences inFrontiers in Endocrinology | www.frontiersin.org 6UCP-1 expression in response to a sympathomimetic agent, such
as isoproterenol or a b3-adrenoceptor agonist, are cell-
autonomous and independent of sympathetic activity in vivo.
A limitation of the present study is a lack of scope to provide a
more complete characterization of the browning process. Other
studies have been conducted with pharmacological agents that
mimic the activity of the SNS (29, 33). Those studies were often
conducted in C57Bl rather than 129 mice, but it is the C57Bl
mice with their lower baseline sympathetic tone where one might
expect to see the greater effect. A comparison of the effects of a
b3-adrenoceptor agonist (for example) in diet-induced obese
C57Bl and 129 mice would be interesting, but this would merit a
paper of its own. Studies that directly measure sympathetic
activity are needed to support our hypothesis. If there are any
such differences, a possible role for glucagon-like peptide-1,
which affects both energy intake and energy expenditure,
should be considered (35). Similarly, whilst not being within
the scope of this report, investigation into the possible role of
other hormones that affect energy intake and metabolism, such
as GLP-1 and adiponectin, ought to be conducted. Quantification
of adipocyte size and number to determine whether the fat depots
are smaller due to cell size or number, along with the adipocytes'
lipid metabolism mechanisms, would also be valuable, as these
parameters have been associated with murine susceptibility/
resistance to high-fat diet (36).
Other workers have also found no effect on body weight, food
intake or energy expenditure of whole-body knock out of GPR17
in C57Bl/6 mice (10), though knocking out GPR17 in C57Bl/6A B
DC
FIGURE 3 | Energy intake in GPR17 +/+ (white bars) and GPR17 -/- (black bars) 129 and Bl6 mice fed standard chow or high fat diet for 18 weeks from age 6 weeks.
Three-day average energy intake [(A)males, (B) females]; energy intake over the first hour of re-feeding after a 16 hour overnight fast [(C)males, (D) females]; energy intake
over the first hour of dark period following a saline or leptin i.p. dose. (N = 6 per group).★P<0.05;★★P<0.01. Values are expressed as means ± S.E.M.September 2021 | Volume 12 | Article 698115
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neurones (12) has been reported to affect energy balance and
glucose homeostasis. Activation of pro-opiomelanocortin
neurons increases sympathetic activity (13), consistent with
our suggestion that the effects on energy balance, glucose
homeostasis and UCP-1 expression of knocking out GPR17
that we report here are mediated by increased sympathetic
activity. As well as the type of knockout, the temperature at
which the mice were housed and the numbers of mice per cage
could play a role in accounting for different findings in GPR17 -/-
mice on the C57Bl/6 background (37–40). The mice were housed
in groups of four to five (10) or three to five (12) in previous
studies, and at a temperature range of 23 ± 1°C. However,
differences in the housing temperature and the number of mice
per cage cannot account for our different findings in GPR17 -/-Frontiers in Endocrinology | www.frontiersin.org 7mice on the C57Bl/6 and 129 backgrounds because mice of both
strains were held in pairs and at a temperature of 19 to 22°C.
The finding that increased energy intake in GPR17 -/- 129
mice is accompanied by increased energy expenditure is far from
unique. For example, acetyl-CoA carboxylase-2 knockout and
11-hydroxysteroid dehydrogenase-1 knockout mice are leaner
than wild-type mice, despite having a higher energy intake (29).
Hyperthyroidism is associated with increased energy intake, and
in some studies in rodents, the thermogenic effect on body
weight of administration of thyroid hormones has been offset
by increased energy intake (41–43). Prolonged strenuous
physical activity also increases food intake (44).
Another example of increased energy expenditure being
accompanied with increased energy intake is when b3-
adrenoceptor agonists are administered daily, by the oral route,A
B
FIGURE 4 | 24-hour energy expenditure [(A) males, (B) females] in GPR17 +/+ (white bars) and GPR17 -/- (black bars) 129 and Bl6 mice fed standard chow or
high fat diet for 18 weeks from age 6 weeks. N = 6 per group). ★P<0.05; ★★P<0.01; ★★★P<0.001. Values are expressed as means ± S.E.M.September 2021 | Volume 12 | Article 698115
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response in lean compared to obese mice, this adaptation
prevents the lean animals from being totally depleted of fat,
their having less fat in total than the amount that is depleted in
obese animals. For example, in one study, treatment for four
weeks with the thermogenic b3-adrenoceptor agonist
BRL26830A resulted in a body lipid content in genetically
obese (ob/ob) mice that was 7 g lower than in control mice. ByFrontiers in Endocrinology | www.frontiersin.org 8contrast, body lipid content in control lean mice was only 4.7 g,
so it was not possible for body lipid content in BRL26830A-
treated mice to be 7 g lower than 4.7 g. In fact, it was 1.2 g lower
(45). Suggested mechanisms for increased energy intake in
response to b3-adrenoceptor agonists in lean animals have
been low plasma non-esterified fatty acid (NEFA) and low
leptin levels in the lean animals (47). NEFA and leptin levels





FIGURE 5 | Oral Glucose tolerance test: blood glucose concentration curves [(A) 129 males, (B) C57Bl6 males, (C) 129 females, (D) C57Bl6 females]; area under
the blood glucose concentration curve [(E) males, (F) females]; fasting plasma insulin concentration [(G) males, (H) females] in GPR17 +/+ (white bars) and GPR17
-/- (black bars) 129 mice fed standard chow or high fat diet for 18 weeks from age 6 weeks. N = 12 per group). ★P<0.05; ★★P<0.01; ★★★P<0.001. Values are
expressed as means ± S.E.M.September 2021 | Volume 12 | Article 698115
Wargent et al. Energy Balance in GPR17-Null Micemice on the 129 but not the C57Bl/6 background. Plasma
triglyceride levels, which have also been proposed to regulate
feeding (48) were similarly low. The hypothesis that low leptin
levels stimulate energy intake to prevent excessive depletion of
lipid stores can, however, be excluded in the case of GPR17-/-
mice on the 129 background. First, the relative increase in energy
intake in GPR17-/- compared to GPR17+/+ mice was similar in
chow and HFD-fed mice. The low leptin hypothesis might
predict a differential diet effect on energy consumption
considering the plasma leptin levels in mice fed a HFD relative
to chow diet. More conclusively, rather than being hypersensitive
to leptin, increased energy intake in the GPR17-/- mice on theFrontiers in Endocrinology | www.frontiersin.org 9129 background was resistant to suppression by administration
of leptin, whereas leptin suppressed energy intake in the wild-
type mice (Figure 8). Thus, the mechanism that accounts for
increased energy intake overrides any effect of leptin. The role of
low NEFA and triglyceride levels in stimulating energy intake
(48, 49) in GPR17-/- mice merits further investigation. Low
plasma levels of these fuels due to increased energy expenditure
may stimulate energy intake by lowering hypothalamic malonyl
CoA levels (50).
In summary, compared to wild-type mice, GPR17 -/- mice of
the 129 strain displayed increased expression of UCP-1 in white
adipose tissue, lower body weight and fat content, and resistanceA
B
FIGURE 6 | Inguinal fat pad UCP-1 mRNA levels [(A) males, (B) females] in GPR17 +/+ (white bars) and GPR17 -/- (black bars) 129 and Bl6 mice fed standard
chow or high fat diet for 18 weeks from age 6 weeks. N = 6 per group). ★P<0.05; ★★P<0.01, ★★★★P<0.01. Values are expressed as means ± S.E.M.September 2021 | Volume 12 | Article 698115




FIGURE 7 | Plasma leptin and lipids in GPR17 +/+ (white bars) and GPR17 -/- (black bars) 129 and Bl6 mice fed standard chow or high fat diet for 18 weeks from
age 6 weeks. Leptin [(A) males, (B) females]; NEFA [(C) males, (D) females]; triglycerides [(E) males, (F) females]. (N = 12 per group). ★P<0.05; ★★P<0.01,
★★★P<0.001; ★★★★P<0.0001. Values are expressed as means ± S.E.M.A B
FIGURE 8 | Energy intake over the first hour of dark period following a saline or leptin i.p. dose in 129 and Bl6 mice [(A) males, (B) females]. (N = 6 per group).
★P<0.05; ★★P<0.01; ★★★P<0.001; ★★★★P<0.0001. Values are expressed as means ± S.E.M.Frontiers in Endocrinology | www.frontiersin.org September 2021 | Volume 12 | Article 69811510
Wargent et al. Energy Balance in GPR17-Null Miceto HFD-induced glucose intolerance. Both energy expenditure
and energy intake were raised. Administration of leptin did not
suppress food intake in GPR17 -/- mice of the 129 strain, whereas
it did suppress food intake in GPR17 +/+ mice. The only
difference between GPR17 -/- and GPR17 +/+ mice of the
C57Bl/6 strain was that the body weight of the female GPR17
-/- mice was lower than that of the GPR17 +/+ mice when the
mice were fed on a standard chow diet. We suggest that the
differences between strains are due to mice of the 129 strain
tending to have a higher sympathetic activity than mice of the
C57Bl/6 strain. Raised energy intake was not a consequence of
low leptin levels and may have been due to a lower plasma level
of a fuel, such as triglyceride or NEFA.DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in
the article/Supplementary Material. Further inquiries can be
directed to the corresponding author.ETHICS STATEMENT
The animal study was reviewed and approved by University of
Buckingham Animal Welfare and Ethical Review Board.Frontiers in Endocrinology | www.frontiersin.org 11AUTHOR CONTRIBUTIONS
EW co-designed, co-ordinated and performed the in vivo study,
and also generated all physiological data and co-wrote the initial
drafts of the manuscript. SA generated the molecular biology
UCP-1 tissue expression data. QL co-designed the study and
generated the transgenic mice. EK co-originated the study and
co-wrote the manuscript. JA wrote a large proportion of the
manuscript. CS principal investigator: co-originated, co-
designed and co-ordinated the institutional groups. All authors
contributed to the article and approved the submitted version.FUNDING
The study was funded in its entirety internally by the Institute
of Translational Medicine, University of Buckingham,
Buckingham, MK18 1EG, UKSUPPLEMENTARY MATERIAL
The SupplementaryMaterial for this article can be found online at:
https://www.frontiersin.org/articles/10.3389/fendo.2021.698115/
full#supplementary-materialREFERENCES
1. Fox A, Feng W, Asal V. What Is Driving Global Obesity Trends?
Globalization or “Modernization”? Global Health (2019) 15(1):32.
doi: 10.1186/s12992-019-0457-y
2. Hu FB. Globalization of Diabetes: The Role of Diet, Lifestyle, and Genes.
Diabetes Care (2011) 34(6):1249–57. doi: 10.2337/dc11-0442
3. Ren H, Orozco IJ, Su Y, Suyama S, Gutiérrez-Juárez R, Horvath TL, et al. G
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